Isolated Diastolic Hypertension and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies With 489,814 Participants

Mingyan Huang, Linzi Long, Ling Tan, Aling Shen, Mi Deng, Yuxuan Peng, Wenwen Yang, Wanqing Li, Yue Wei, Meng Li, Feifei Liao, Chao Liu, Aimei Lu, Hua Qu, Changgeng Fu, Keji ChenFrontiers in Cardiovascular Medicine 2022 · DOI

TL;DR

This systematic review and meta-analysis of nearly 500,000 participants reveals that Isolated Diastolic Hypertension (IDH)—high diastolic pressure despite normal systolic pressure—is a significant risk factor for major cardiovascular events and strokes. The risk is particularly pronounced in adults under 55 and Asian populations, suggesting that "bottom number" hypertension should not be ignored in clinical practice.

What Problem Does This Paper Address?

Hypertension is usually defined by two numbers: systolic (the "top" number) and diastolic (the "bottom" number). While systolic hypertension is a well-known killer, Isolated Diastolic Hypertension (IDH)—defined here as a systolic blood pressure < 140 mmHg but a diastolic pressure ≥ 90 mmHg—has historically been neglected.

Clinicians and researchers have long debated whether IDH actually increases the risk of heart disease or death. Conflicting guidelines from major organizations (like the ACC/AHA vs. the ESC) have only added to the confusion. This paper aims to settle the debate by aggregating data from multiple long-term cohort studies to determine if IDH is a true independent risk factor for cardiovascular mortality and various types of stroke.

Methods

The authors conducted a systematic review and meta-analysis following PRISMA and MOOSE guidelines. They searched major medical databases (PubMed, Embase, Cochrane Library, and Web of Science) for cohort studies published through July 2021.

Key methodological features included:

  • Standardized Definition: They focused on the 2018 European Society of Cardiology (ESC) definition of IDH (SBP < 140 and DBP ≥ 90 mmHg).
  • Statistical Modeling: They used random-effects models to calculate pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs).
  • Quality Assessment: The Newcastle–Ottawa scale was used to ensure the included studies were of high methodological quality.
  • Subgroup Analysis: To find the "why" behind the data, they stratified results by age, geographic location, and blood pressure measurement methods.

Datasets

The study synthesized data from 15 cohort studies (spanning 13 articles).

  • Total Participants: 489,814 individuals.
  • Follow-up Duration: Ranging from 4.3 to 29 years.
  • Geographic Diversity: Studies included populations from Asia (China, Japan, Iran), the United States, and Europe (Finland, UK, Sweden).

Key Insights and Ideas

  • The "Young Adult" Risk: One of the most striking findings is that IDH is significantly more dangerous for younger patients (mean age ≤ 55). In older populations, systolic pressure tends to be a better predictor of risk, but in younger adults, an elevated diastolic pressure is a major red flag.
  • Geographic Disparity: The association between IDH and cardiovascular events was statistically significant in Asian populations but not in American or European subgroups. The authors suggest this might be due to differences in awareness, treatment rates, or genetic predispositions.
  • Stroke Specificity: IDH showed a stronger correlation with hemorrhagic stroke (bleeding in the brain) than with ischemic stroke (clots). This suggests that high diastolic pressure may put specific types of mechanical stress on the cerebral vasculature.
  • Measurement Matters: The researchers found that the method of measuring blood pressure (mercury sphygmomanometer vs. automatic digital monitor) contributed to the heterogeneity of the results, highlighting the need for standardized clinical protocols.

Key Results

The meta-analysis found that compared to people with normal blood pressure, those with IDH had:

  • 28% higher risk of composite cardiovascular events (HR 1.28).
  • 45% higher risk of cardiovascular mortality (HR 1.45).
  • 44% higher risk of all-cause stroke (HR 1.44).
  • 64% higher risk specifically for hemorrhagic stroke (HR 1.64).

Crucially, IDH was not significantly associated with an increase in all-cause mortality or ischemic stroke. In the subgroup analysis, the increased risk for composite CV events remained significant for those ≤ 55 years old and those in Asia, but disappeared for the elderly and Western populations.

Limitations and Future Work

The authors acknowledge several limitations:

  • Definition Inconsistency: While they standardized to the ESC definition, the primary studies they pulled from may have had slight variations in how they recorded data.
  • Heterogeneity: There was significant variation between studies, particularly regarding how blood pressure was measured and which confounding variables (like diet or exercise) were adjusted for.
  • Lack of Clinical Trials: While this study shows a correlation between IDH and risk, there is still a lack of randomized controlled trials (RCTs) specifically testing whether treating IDH with medication actually reduces these risks.

Future Direction: The authors call for more age-stratified research and clinical trials to determine the cost-effectiveness of pharmacological intervention for IDH, especially in younger, asymptomatic adults.

Summary updated

Abstract

Background: The association between isolated diastolic hypertension (IDH) and cardiovascular events has been inconsistently reported. This meta-analysis of cohort studies was designed to investigate the effect of the 2018 European Society of Cardiology (ESC) definition of IDH on the risk of composite cardiovascular events, cardiovascular mortality, all-cause mortality, and all strokes including ischemic stroke (IS) and hemorrhagic stroke (HS). Methods: PubMed, Embase, the Cochrane Library, and Web of Science were searched from inception to July 6, 2021. Cohort studies that investigated the association between IDH and cardiovascular events risk, compared to normotension, were included. Pooled hazard ratios (HRs) and 95% CIs were calculated using a random-effects models and heterogeneity was evaluated using Q -test and I 2 statistic. The robustness of the associations was identified using sensitivity analysis. The methodological quality of the studies was assessed using the Newcastle–Ottawa scale. Publication bias was assessed using funnel plot, trim-and-fill method, Begg's test, and Egger's test. Results: A total of 15 cohort studies (13 articles) including 489,814 participants were included in this meta-analysis. The follow-up period ranged from 4.3 to 29 years. IDH was significantly associated with an increased risk of composite cardiovascular events (HR 1.28, 95% CI: 1.07–1.52, p = 0.006), cardiovascular mortality (HR 1.45, 95% CI: 1.07–1.95, p = 0.015), all strokes (HR 1.44, 95% CI: 1.04–2.01, p = 0.03), and HS (HR 1.64, 95% CI: 1.18–2.29, p = 0.164), but not associated with all-cause mortality (HR 1.20, 95% CI: 0.97–1.47, p = 0.087) and IS (HR 1.56, 95% CI: 0.87–2.81, p = 0.137). Subgroup analysis further indicated that IDH in the younger patients (mean age ≤ 55 years) and from Asia were significantly associated with an increased risk of composite cardiovascular events, while the elderly patients (mean age ≥ 55 years), Americans, and Europeans were not significantly associated with an increased risk of composite cardiovascular events. Conclusion: This meta-analysis provides evidence that IDH defined using the 2018 ESC criterion is significantly associated with an increased risk of composite cardiovascular events, cardiovascular mortality, all strokes and HS, but not significantly associated with all-cause death and IS. These findings also emphasize the importance for patients with IDH to have their blood pressure within normal, especially in the young adults and Asians. Trial Registration: PROSPERO, Identifier: CRD42021254108.
BibTeX
@inproceedings{huang2022isolated,
  author = {Mingyan Huang and Linzi Long and Ling Tan and Aling Shen and Mi Deng and Yuxuan Peng and Wenwen Yang and Wanqing Li and Yue Wei and Meng Li and Feifei Liao and Chao Liu and Aimei Lu and Hua Qu and Changgeng Fu and Keji Chen},
  title = {{Isolated Diastolic Hypertension and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies With 489,814 Participants}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2022},
  doi = {10.3389/fcvm.2021.810105},
}
Figure